Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolution Matrix) in Subjects Undergoing Foot and Ankle Fusion

NCT00988338 is registered in ClinicalTrials.gov with Orthofix Inc. as lead sponsor.

NCT NCT00988338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolution Matrix) in Subjects Undergoing Foot and Ankle Fusion
Lead sponsor
Orthofix Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
January 31, 2013
Enrollment
106 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

calcaneocuboid arthrodesis, double arthrodesis (i.e. calcaneocuboid and talonavicular), subtalar arthrodesis, talonavicular arthrodesis, tibiotalar arthrodesis, triple arthrodesis (i.e. subtalar, calcaneocuboid, and talonavicular)